Home Cart 0 Sign in  

[ CAS No. 710348-69-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 710348-69-9
Chemical Structure| 710348-69-9
Structure of 710348-69-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 710348-69-9 ]

Related Doc. of [ 710348-69-9 ]

Alternatived Products of [ 710348-69-9 ]

Product Details of [ 710348-69-9 ]

CAS No. :710348-69-9 MDL No. :MFCD09260491
Formula : C13H17BN2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :LQVSXEXWXILGBH-UHFFFAOYSA-N
M.W : 260.10 Pubchem ID :43811065
Synonyms :

Calculated chemistry of [ 710348-69-9 ]

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.46
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 75.4
TPSA : 67.11 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.79 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 1.55
Log Po/w (WLOGP) : 1.16
Log Po/w (MLOGP) : 0.95
Log Po/w (SILICOS-IT) : 2.01
Consensus Log Po/w : 1.13

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.71
Solubility : 0.503 mg/ml ; 0.00193 mol/l
Class : Soluble
Log S (Ali) : -2.57
Solubility : 0.702 mg/ml ; 0.0027 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.42
Solubility : 0.00987 mg/ml ; 0.0000379 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.9

Safety of [ 710348-69-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 710348-69-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 710348-69-9 ]
  • Downstream synthetic route of [ 710348-69-9 ]

[ 710348-69-9 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 39513-26-3 ]
  • [ 73183-34-3 ]
  • [ 710348-69-9 ]
YieldReaction ConditionsOperation in experiment
44% With potassium acetate In DMF (N,N-dimethyl-formamide) at 95℃; 5-BROMO-1, 3-dihydro-benzoimidazol-2-one (20.0 g, 93.9 mmol) is dissolved in argon purged anhydrous DMF (150 mL). To this solution is added bis (pinacolato) diboron (28.6 g, 113 mmol), KOAC (27.6 g, 282 mmol), and PDCL2 (DPPF), 1: 1 complex with CH2C12 (7.67 g, 9.40 mmol). The reaction is heated to 95 °C overnight with mechanical stirring then cooled to room temperature and diluted with brine (500 mL) and EtOAc (750 mL). The mixture is filtered to remove a dark brown solid, which is washed thoroughly with EtOAc. The layers are separated and the organics washed with water (3 x 500 mL), then dried (MGS04), filtered and evaporated under reduced pressure. Trituration with 1: 1 CH2CL2/HEXANES affords the product (10.9 g, 44percent). RF 0. 52 (silica gel, 85: 15 CH2C4LMEOH) ; mp 313-315 °C (dec) ;APOS;H NMR (300 MHz, DMSO-d6) 21. 27 (s, 12 H), 6.92 (d, J= 7.7 Hz, 1H), 7.17 (s, 1H), 7.28 (d, J= 7.7 Hz, 1H), 10.62 (s, 1H), 10.74 (s, 1H) ; APCI MS m/z 261 [CL3HL7BN203 + H] + ; HPLC = 98.3percent, TR= 18. 3 min; Analysis for C13HL7BN203 : C, 57.07 ; H, 6.82 ; N, 10.24. Found: C, 56.69 ; H, 6.44 ; N, 10.21. HPLC conditions: Waters Symmetry C18 column (4.6 mm x 250 mm); 95: 5 to 0: 100 WATER/MECN ; 1.0 mL/min (25 min), D = 254 nm
41% With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate In N,N-dimethyl-formamide at 95℃; for 16 h; Inert atmosphere To a round-bottomed flask containing DMF (35 mL) was added 5-bromo-1 ,3—dihydro- benzimidazo-2one (5.Og, 23 mmo), and the resu[ting soution was purged with nitrogen for 15 minutes. To this soution were added successivey bis(pinacoato)diboron (7.2g, 28mmo), potassium acetate (6.9g, 70 mmo), and PdC2(dppf)0H2C2 (1 .7g, 2.4 mmd). After heating at 95 °C for 16 h, the back mixture was coded to rt and di’uted with brine (50 mL) and EtOAc (75 mL). The resu[ting precipitate was removed by fiftration and washed with EtOAc. The fiftrate was transferred to a separatory funnd and the ayers separated. The organic ayer was washed with water (3 x 50 mL), dried (Na2SO4), fiftered andconcentrated in vacuo. Trituration of the crude residue with DOM provided the desired product as a white soid (2.5g, 41 percent yied). MS (ES): masss cacd. for 013H17BN203, 260.1; m/zfound, 261.2 [M+H1. 1H NMR (400 MHz, DMSO.-d6) 310.76 (s, IH), 10.65 (s, IH), 7.29 (dd, J= 7,7, 1.0 Hz, IH), 7.18 (s, IH), 6.92 (d, J= 7.5 Hz, IH), 127 (5, 12H).
Reference: [1] Patent: WO2004/52847, 2004, A2, . Location in patent: Page 298
[2] Patent: WO2016/176449, 2016, A1, . Location in patent: Page/Page column 94; 95; 97
[3] Patent: WO2007/80382, 2007, A1, . Location in patent: Page/Page column 133
  • 2
  • [ 851883-08-4 ]
  • [ 530-62-1 ]
  • [ 710348-69-9 ]
YieldReaction ConditionsOperation in experiment
63.2% at 23℃; for 16 h; Step B: 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-dihydro-2H-benzo[d]imidazol- 2-one. To a solution of 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzene-1,2-diamine (17 mmol) in EtOAc (360 mL) was added 1,1'-carbonyldiimidazole (CDI) (3.0 g, 19 mmol). The resulting mixture was stirred at 23 °C for 16 h. The reaction mixture was diluted with DCM and the resulting white solid was filtered and washed with MeOH to afford the title compound (10.8 g, 63.2percent).
Reference: [1] Patent: WO2016/176457, 2016, A1, . Location in patent: Page/Page column 97
[2] Patent: WO2009/14620, 2009, A1, . Location in patent: Page/Page column 43; 23
  • 3
  • [ 851883-08-4 ]
  • [ 32315-10-9 ]
  • [ 710348-69-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2009, vol. 52, # 24, p. 8010 - 8024
  • 4
  • [ 833486-94-5 ]
  • [ 710348-69-9 ]
Reference: [1] Patent: WO2016/176457, 2016, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 710348-69-9 ]

Organoboron

Chemical Structure| 214360-60-8

[ 214360-60-8 ]

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

Similarity: 0.82

Chemical Structure| 171364-78-6

[ 171364-78-6 ]

N,N-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

Similarity: 0.81

Chemical Structure| 874363-18-5

[ 874363-18-5 ]

N-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylamide

Similarity: 0.81

Chemical Structure| 1256360-63-0

[ 1256360-63-0 ]

N-Isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

Similarity: 0.79

Chemical Structure| 267221-88-5

[ 267221-88-5 ]

N,N-Diphenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

Similarity: 0.79

Amides

Chemical Structure| 214360-60-8

[ 214360-60-8 ]

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

Similarity: 0.82

Chemical Structure| 874363-18-5

[ 874363-18-5 ]

N-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylamide

Similarity: 0.81

Chemical Structure| 1256358-90-3

[ 1256358-90-3 ]

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one

Similarity: 0.76

Chemical Structure| 1454682-74-6

[ 1454682-74-6 ]

1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea

Similarity: 0.75

Chemical Structure| 1160790-84-0

[ 1160790-84-0 ]

1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one

Similarity: 0.74

Related Parent Nucleus of
[ 710348-69-9 ]

Benzimidazoles

Chemical Structure| 1007206-54-3

[ 1007206-54-3 ]

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole

Similarity: 0.69

Chemical Structure| 1021918-86-4

[ 1021918-86-4 ]

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole-1-carboxylate

Similarity: 0.61

Chemical Structure| 1231930-37-2

[ 1231930-37-2 ]

4-Fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole

Similarity: 0.58

Chemical Structure| 1256387-87-7

[ 1256387-87-7 ]

(1R,3S,4S)-tert-Butyl 3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate

Similarity: 0.54

Chemical Structure| 615-16-7

[ 615-16-7 ]

2-Hydroxybenzimidazole

Similarity: 0.51